Literature DB >> 1520424

Attitudes of medical school faculty toward gifts from the pharmaceutical industry.

J W Banks1, A G Mainous.   

Abstract

The American Medical Association (AMA) has recently published guidelines for the receipt of gifts from industry representatives. To examine faculty members' attitudes toward that AMA policy as it pertains to gifts from the pharmaceutical industry, the authors surveyed the faculty of the University of Kentucky College of Medicine in 1991. Of 462 faculty members, 248 (54%) completed the questionnaires. The faculty generally agreed with the AMA guidelines. A majority of the faculty believed that personal relationships had the potential to influence prescribing patterns but that gifts, in general, did not greatly influence prescribing behaviors. Compared with the 169 M.D. faculty, the 69 Ph.D. faculty significantly favored more restrictive policies (p less than .001). The authors discuss both the ethical considerations and the utility of guidelines for physician-industry interactions.

Keywords:  American Medical Association; Empirical Approach; Health Care and Public Health; University of Kentucky College of Medicine

Mesh:

Year:  1992        PMID: 1520424     DOI: 10.1097/00001888-199209000-00017

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  8 in total

1.  The relationship between physicians and the pharmaceutical industry: ethical problems with the every-day conflict of interest.

Authors:  Richard L Allman
Journal:  HEC Forum       Date:  2003-06

2.  Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.

Authors:  James L Wofford; Christopher A Ohl
Journal:  BMC Med Educ       Date:  2005-02-08       Impact factor: 2.463

Review 3.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

4.  Prescribers and pharmaceutical representatives: why are we still meeting?

Authors:  Melissa A Fischer; Mary Ellen Keough; Joann L Baril; Laura Saccoccio; Kathleen M Mazor; Elissa Ladd; Ann Von Worley; Jerry H Gurwitz
Journal:  J Gen Intern Med       Date:  2009-05-08       Impact factor: 5.128

5.  Sunshine Act: shedding light on inaccurate disclosures at a gynecologic annual meeting.

Authors:  Jennifer C Thompson; Katherine A Volpe; Lindsay K Bridgewater; Fares Qeadan; Gena C Dunivan; Yuko M Komesu; Sara B Cichowski; Peter C Jeppson; Rebecca G Rogers
Journal:  Am J Obstet Gynecol       Date:  2016-06-16       Impact factor: 8.661

6.  Physicians and drug representatives: exploring the dynamics of the relationship.

Authors:  Susan Chimonas; Troyen A Brennan; David J Rothman
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

7.  Pharmacists' and physicians' perception and exposure to drug promotion: A Saudi study.

Authors:  Noha M Zaki
Journal:  Saudi Pharm J       Date:  2014-03-06       Impact factor: 4.330

8.  Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review.

Authors:  Tamara Lotfi; Rami Z Morsi; Nada Zmeter; Mohammad W Godah; Lina Alkhaled; Lara A Kahale; Hala Nass; Hneine Brax; Racha Fadlallah; Elie A Akl
Journal:  BMC Res Notes       Date:  2015-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.